In the BioHarmony Drug Report Database

"Preview" Icon

Sodium zirconium cyclosilicate

Lokelma (sodium zirconium cyclosilicate) is a small molecule pharmaceutical. Sodium zirconium cyclosilicate was first approved as Lokelma on 2018-03-22. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia. Lokelma’s patents are valid until 2035-10-14 (FDA).

 

Trade Name

 

Lokelma
 

Common Name

 

sodium zirconium cyclosilicate
 

ChEMBL ID

 

CHEMBL3301592
 

Indication

 

hyperkalemia
 

Drug Class

 

Quaternary ammonium derivatives

Image (chem structure or protein)

Sodium zirconium cyclosilicate structure rendering